Cell and Gene Therapy - Cytiva (formerly GE Healthcare Life Sciences)

The cell and gene therapy industry is evolving at a rapid pace. Whether your goal is improving one process step or designing a platform to treat thousands, GE Healthcare Life Sciences can support you through this changing ecosystem.

Supporting progress

To keep you and the industry moving forward, consider end-to-end solutions from equipment and software that drive consistency to reliable reagents, automated data collection, and digital traceability. Let us work with you, not for you, to pass on cell and gene therapy knowledge and experience.

Enabling customer outcomes

Removing barriers

Wherever you are in the development cycle, you might encounter obstacles that block your path. To develop your process or manufacture the viral vector you need to continue your gene therapy work, ask about our global services. Our teams use the same automated technologies that can be integrated across your workflow to build in-house capabilities.

Read about services and manufacturing platforms

Sharing knowledge

To move forward with confidence, you need more than just a vendor. Gain access to knowledge and expertise amassed over decades of R&D, investment, acquisitions, and global collaborations when you work with GE Healthcare. For example, learn how collaborating with the Centre for Commercialization of Regenerative Medicine (CCRM) is expected to accelerate all facets of cell therapy manufacturing.

Access articles, videos, and other resources

Privacy Policy Update

Proven past. New beginning.

Every step of the way, it´s personal

Supporting progress

Removing barriers

Sharing knowledge

Cell therapy

Gene therapy

Cord blood banking

Point of care